80169 Drug assay everolimus
Also known as: everolimus level, Afinitor level
Laboratory quantitative drug assay for everolimus to assess serum level for therapeutic drug monitoring in transplantation and immunosuppression.
In Plain Language
everolimus blood test; transplant medication level
Clinical Context
Monitors everolimus (mammalian target of rapamycin inhibitor) levels in transplant recipients and cancer patients on targeted therapy.
RVU Information
CPT 80169 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 80169?
CPT 80169 (Drug assay everolimus) is a Pathology & Lab code. Laboratory quantitative drug assay for everolimus to assess serum level for therapeutic drug monitoring in transplantation and immunosuppression.
Who uses CPT code 80169?
CPT 80169 is used by Pathology, Transplant Surgery, Oncology. Monitors everolimus (mammalian target of rapamycin inhibitor) levels in transplant recipients and cancer patients on targeted therapy.
When is CPT 80169 used?
Monitors everolimus (mammalian target of rapamycin inhibitor) levels in transplant recipients and cancer patients on targeted therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.